The last DEEP-2 Investigator Meeting was organised on April 14th 2016 in the framework of the 7th DEEP General Assembly in Padua. It was designed as a guided roundtable where CRAs and Principal Investigators from main recruiting sites had the opportunity to depict the situation at their […]
The DEEP project has received research funding from the European Union under the 7th Framework Programme
clinical trials | DEEP Project
DEEP-2 study completed the enrollment!
A big project milestone has been reached as the last few patients have been randomized. Thanks to the last achievements and efforts made by the PIs to recruit patients, the DEEP-2 Study has finally completed the enrollment.
The last patients were included […]
DEEP-2: an update of the clinical centres involved
Another step forward has been made toward the enrollment of new patients in the DEEP-2 study, a phase III multicentre, randomised, open label, non-inferiority active-controlled trial aiming at comparing for the first time the efficacy of deferiprone (DFP) vs deferasirox (DFX) in paediatric patients affected […]
The Story of the project as described in the Scientific report to the EC
The most important achievements and activities carried out by the project have been collected and included in the DEEP Scientific Report related to the period from 01/01/2014 to 30/06/2015 which has been submitted to the European Commission on September 2015.
The report provided a […]